Prostate cancer is cancer that occurs in the prostate. It is a form of cancer that begins in the gland cells of the prostate, which is found only in males. It is the second-leading cause of cancer death for men in the United States. Prostate cancer can be cured, when detected and treated early. The vast majority of prostate cancer cases (more than 90 percent) are discovered in the early stages, making the tumors more likely to respond to treatment. Prostate cancer treatment can include active surveillance, surgery, radiation therapy, hormonal therapy, chemotherapy, immunotherapy, and bisphosphonate therapy.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/1257
Increasing prevalence of prostate cancer around the world is expected to boost growth of the global prostate cancer therapeutics market over the forecast period. For instance, according to the American Cancer Society, in 2017, more than 161,360 new cases of cancer diagnosed in the United States and 26,730 people died from the disease. The most common sites for prostate cancer to metastasize are the lungs, the lymph nodes, the seminal vesicles, and various bones around the hips and the pelvic region. As per the World Cancer Research Fund International, around 1 million cases of prostate cancer were reported worldwide in 2012.
Moreover, approvals of novel therapies and increasing research & development activities are expected to augment the growth of the global prostate cancer therapeutics market. For instance, Eligard developed by Tolmar Pharmaceuticals, Inc. is marketed in the U.S., New Zealand, and Australia by Tolmar, and by the following partners in the remaining territories: HanAll (South Korea), Key Oncologics (South Africa), Sanofi (Canada), and Astellas (Europe, Asia, and MENA), for the palliative treatment of advanced prostate cancer.
Key players operating in the global prostate cancer therapeutics market are AbbVie, Inc., Endo Pharmaceuticals, Tolmar Pharmaceuticals, Ipsen Group, Pfizer Inc., AstraZeneca Plc, Bayer AG, Sanofi-Aventis, Astella, Inc, Johnson & Johnson, and Dendreon Corporation (Sanpower Group Co. Ltd.), among others.
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1257
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Prostate Cancer Therapeutics Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Prostate Cancer Therapeutics Industry Impact
Chapter 2 Global Prostate Cancer Therapeutics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Prostate Cancer Therapeutics (Volume and Value) by Type
2.3 Global Prostate Cancer Therapeutics (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Prostate Cancer Therapeutics Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Prostate Cancer Therapeutics Market Analysis
Chapter 6 East Asia Prostate Cancer Therapeutics Market Analysis
Chapter 7 Europe Prostate Cancer Therapeutics Market Analysis
Chapter 8 South Asia Prostate Cancer Therapeutics Market Analysis
Chapter 9 Southeast Asia Prostate Cancer Therapeutics Market Analysis
Chapter 10 Middle East Prostate Cancer Therapeutics Market Analysis
Chapter 11 Africa Prostate Cancer Therapeutics Market Analysis
Chapter 12 Oceania Prostate Cancer Therapeutics Market Analysis
Chapter 13 South America Prostate Cancer Therapeutics Market Analysis
Chapter 14 Company Profiles and Key Figures in Prostate Cancer Therapeutics Business
Chapter 15 Global Prostate Cancer Therapeutics Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/1257
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027